{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Trauma patients at 12 level 1 North American trauma centers were randomized based on transfusion ratios as described in the PROPPR trial."
      },
      "Participants": {
        "score": 1,
        "evidence": "Trauma patients at 12 level 1 North American trauma centers"
      },
      "Intervention": {
        "score": 2,
        "evidence": "comparing DCL versus definitive surgical management (DSM)"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Primary outcomes were 24-hour and 30-day mortality."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "randomized based on transfusion ratios as described in the PROPPR trial"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "329 patients underwent emergent laparotomy: 213 DCL (65%) and 116 DSM (35%)."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "329 patients underwent emergent laparotomy: 213 DCL (65%) and 116 DSM (35%)."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "24-hour mortality was 19% with DCL versus 4% (p<0.001); 30-day mortality was 28% with DCL versus 19% (p<0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Sepsis and VAP occurred more frequently with DCL (p<0.05)."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 13,
    "max_score": 25
  },
  "model": "gpt-4o"
}